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HYPOTHESIS
Primate embryogenesis predicts the hallmarks of human naïve
pluripotency
Thorsten Boroviak1,* and Jennifer Nichols1,2
ABSTRACT
Naïve pluripotent mouse embryonic stem cells (ESCs) resemble the
preimplantation epiblast and efficiently contribute to chimaeras.
Primate ESCs correspond to the postimplantation embryo and fail
to resume development in chimaeric assays. Recent data suggest
that human ESCs can be ‘reset’ to an earlier developmental stage,
but their functional capacity remains ill defined. Here, we discuss how
the naïve state is inherently linked to preimplantation epiblast identity
in the embryo. We hypothesise that distinctive features of primate
development provide stringent criteria to evaluate naïve pluripotency
in human and other primate cells. Based on our hypothesis, we define
12 key hallmarks of naïve pluripotency, five of which are specific to
primates. These hallmarks may serve as a functional framework to
assess human naïve ESCs.
KEY WORDS: Amnion, Epiblast, Extraembryonic, Naïve
pluripotency, Postimplantation, Primate
Introduction
Embryonic stem cells (ESCs) have been derived from
preimplantation embryos of a variety of non-rodent mammals,
including rabbit (Graves and Moreadith, 1993), cow (Gjørret and
Maddox-Hyttel, 2005), pig (Notarianni et al., 1991), sheep
(Notarianni et al., 1991), marmoset monkey (Sasaki et al., 2005;
Thomson et al., 1996), rhesus monkey (Thomson et al., 1995) and
human (Ludwig et al., 2006; Thomson et al., 1998). However, in
contrast to mouse and rat ESCs, none of the cell lines from non-
rodent species has convincingly demonstrated contribution to
chimaeras when injected into a host embryo. Conventional human
ESCs have a dramatically different transcriptome and methylome
compared with the inner cell mass (ICM) of the human blastocyst
from which they derive (Guo et al., 2014; Yan et al., 2013). This
suggests that the conditions in which the cells are cultured fail to
capture the transient developmental programme of the embryo.
Instead, human and non-human primate ESCs share distinctive
features with cells derived from the mouse postimplantation
epiblast, which has led to the proposition that they represent a
later stage of development (Brons et al., 2007; Nichols and Smith,
2009; Tesar et al., 2007). These findings have sparked efforts to
reset conventional primate, and in particular human, ESCs to an
earlier developmental state, more akin to mouse ESCs. These
approaches were initially dependent upon overexpression of potent
pluripotency factors (Buecker et al., 2010; Hanna et al., 2010; Li
et al., 2009; Wang et al., 2011), but recently several culture
conditions were reported in which it is possible to convert
conventional human ESCs from ʻprimed’ (postimplantation) to
ʻnaïve’ (preimplantation) pluripotency in the absence of continuous
transgene expression (Chan et al., 2013; Chen et al., 2015a,b;
Duggal et al., 2015; Gafni et al., 2013; Takashima et al., 2014;
Theunissen et al., 2014; Valamehr et al., 2014; Ware et al., 2014).
Since ethical considerations prohibit the functional evaluation of
these putatively naïve pluripotent human ESCs in germline
chimaera assays, stringent criteria are needed to define naïve
pluripotency in human and other primates.
In this Hypothesis article, we advocate that preimplantation
epiblast identity is imperative for the naïve state in human and non-
human primates. We discuss the fundamental differences between
primate and rodent development and hypothesise that these
differences might provide stringent criteria to evaluate naïve
pluripotency in human and other primate cells. Based on this
hypothesis, we extract 12 hallmarks of naïve pluripotency from
early histological studies and recent discoveries in primate
embryology. Seven of these equally apply to mouse ESCs; the
remaining five reflect the primate-specific adaptations of early
development. Our hypothesis provides a testable framework to
assess naïve pluripotency in primates – a timely requirement in the
light of recent achievements in resetting human ESCs.
Capturing pluripotent states from the embryo
Mammalian embryos establish an unrestricted state of embryonic
potential in the epiblast prior to implantation. After fertilisation,
the unicellular zygote undergoes several rounds of cleavage
divisions, resulting in a progressively greater number of
increasingly smaller cells. These cells are called blastomeres and
subsequently go through compaction. During this process, the
outer cells establish apical-basal polarity and are directed towards
the trophoblast lineage, a prerequisite for blastocyst formation.
Interior cells become ICM and gradually diverge into pluripotent
epiblast and extraembryonic hypoblast (also called primitive
endoderm) (Chazaud et al., 2006; Frankenberg et al., 2011; Plusa
et al., 2008; Ralston and Rossant, 2008; Rossant and Tam, 2009;
Schrode et al., 2014; Strumpf et al., 2005). At the mid-to-late
blastocyst stage, cleavage ceases (Aiken et al., 2004) as cells gain
the capacity to replenish cytosol and organelles before division
and become autopoietic (ʻself-creating’). The ICM lineages
segregate irreversibly (Grabarek et al., 2012) and the founding
cell population of the foetus is established in the preimplantation
epiblast.
In mouse, this stage of development can be captured in the form
of ESCs (Brook and Gardner, 1997; Evans and Kaufman, 1981;
Martin, 1981). ESCs cultured with mitogen-activated protein kinase
kinase (Mek) and Gsk3β inhibition plus leukaemia inhibitory factor
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(2i/LIF) (Ying et al., 2008) correspond to the preimplantation
epiblast in terms of gene expression (Boroviak et al., 2014) and
functionally contribute to chimaeras upon injection into a host
blastocyst (Bradley et al., 1984; Ying et al., 2008). The unrestricted
potential of preimplantation epiblast and ESCs to give rise robustly
to all somatic lineages and the germline has been termed ʻnaïve’
pluripotency (Nichols and Smith, 2009). By contrast, cell lines
derived from the mouse postimplantation epiblast are called epiblast
stem cells (EpiSCs). Although EpiSCs express several pluripotency
factors and differentiate into the three germ layers in vitro as well as
in teratoma assays, they have lost their ability to re-enter embryonic
preimplantation development consistently in blastocyst chimaera
assays (Brons et al., 2007; Tesar et al., 2007). However, they do
contribute to somatic lineages when introduced into the
postimplantation embryo in vitro (Huang et al., 2012) and express
early markers of lineage specification (Brons et al., 2007; Tesar
et al., 2007). EpiSCs share features, including gene expression, with
anterior primitive streak cells of the late gastrula, a cell population
heterogeneously ʻprimed’ for successive lineage commitment
(Kojima et al., 2014). This renders EpiSCs predisposed to
differentiate into germ layer derivatives to a variable degree
(Bernemann et al., 2011; Kojima et al., 2014). Therefore, this
stage of pluripotency is referred to as ʻprimed’ (Nichols and Smith,
2009).
Primate ESCs in conventional culture conditions containing
knockout serum replacement (KSR) and basic fibroblast growth
factor (bFGF; also known as FGF2) have consistently failed to
produce chimaeras (Okano et al., 2012) and share distinctive
features with primed mouse EpiSCs, despite their blastocyst origin
(Brons et al., 2007; Tesar et al., 2007). Conventional primate ESCs
rely on FGF and activin/Nodal signalling for self-renewal and
exhibit a flat colony morphology, low clonogenicity, repressive
epigenetic marks, and differentiation bias (Bernemann et al., 2011;
Brons et al., 2007; Han et al., 2010; Nichols and Smith, 2009; Tesar
et al., 2007). Recent transcriptome analysis of primate pre- and
postimplantation embryos revealed that human and monkey ESCs
show highest similarity to the late postimplantation epiblast
(Nakamura et al., 2016). This confirms the proposition that
primate ESCs in conventional culture represent a later
developmental state than mouse ESCs (Brons et al., 2007;
Nichols and Smith, 2009; Rossant, 2008; Tesar et al., 2007).
In rodents, primed cells can be reverted to a naïve state from
EpiSCs (Festuccia et al., 2012; Guo et al., 2009; Martello et al.,
2013; Yang et al., 2010) and from the in vivo postimplantation
epiblast (Bao et al., 2009). A recent flurry of reports described the
derivation of so-called naïve pluripotent human ESCs (Chan et al.,
2013; Chen et al., 2015a,b; Duggal et al., 2015; Gafni et al., 2013;
Takashima et al., 2014; Theunissen et al., 2014; Valamehr et al.,
2014; Ware et al., 2014; reviewed by Ávila-González et al., 2016).
All of these conditions are modifications of the 2i/LIF culture
regime developed for efficient mouse ESC derivation and culture.
The majority contain additional cytokines, such as activin A or
bFGF and generally require feeder cells. Transcriptome comparison
of naïve human ESCs with early embryos suggests that 5i/L/FA (2i/
LIF plus inhibitors of BRAF, ROCK and SRC plus activin A and
FGF) cells (Theunissen et al., 2014) and t2iL+Gö (2i/LIF with
lower, titrated levels of Gsk3β inhibitor plus aPKC inhibitor) reset
cells (Takashima et al., 2014) exhibit distinct features of in vivo
preimplantation development (Huang et al., 2014; Pastor et al.,
2016). Chimaeric foetuses have been generated with non-human
primate ESCs (Chen et al., 2015b), but low chimaerism and a lack of
lineage marker analysis after morula injection prevent definitive
conclusions at present. Human ESCs cannot be tested for their full
developmental potential to make germline chimaeras for ethical
reasons. Analysis of mid-gestation chimaeras for contribution from
human ESCs has been met with inconsistent success, marking this
controversial technique as an unreliable readout for determining
human pluripotency (Gafni et al., 2013; Theunissen et al., 2016).
This further highlights the need for alternative functional assays to
discriminate between human primed and naïve pluripotent states.
We hypothesise that such distinguishing features can be gleaned
from early primate development.
Distinctive features of early primate development
Embryogenesis in primates is protracted compared with rodents.
Several differences in developmental timing emerge directly after
fertilisation: the pluripotency factor POU5F1 (OCT4) is barely
expressed in human embryos until the 8-cell stage, whereas mouse
Pou5f1 transcripts are detected in the zygote and are initially
downregulated, then upregulated at the 8-cell stage (Blakeley et al.,
2015; Palmieri et al., 1994). Moreover, human embryos activate
their genome at the 4- to 8-cell stage (Braude et al., 1988; Vassena
et al., 2011; Yan et al., 2013), rather than at the 2-cell stage as in
mouse (Flach et al., 1982). Both rodent and primate embryos
undergo several rounds of cleavage divisions (Fig. 1A,B, Carnegie
stage 2), but compaction occurs slightly later in primates between
the 16-cell and the 32-cell stage, as compared with the 16-cell stage
in mouse. The first two lineage decisions, however, are conserved
between rodents and primates: outer blastomeres form intercellular
connections and establish apical-basal polarity, which pre-empts the
first lineage decision between ICM and trophoblast (Fig. 1A,B,
Carnegie stage 3); the blastocyst expands and subsequently initiates
the second lineage decision, whereby ICM cells segregate into
pluripotent epiblast and extraembryonic hypoblast by Carnegie
stage 3-2 (Fig. 1A,B). Rodent and primate extraembryonic tissues
exhibit apical-basal polarity, with the trophoblast facing outwards
and hypoblast towards the blastocoel (Enders and Schlafke, 1981;
Nadijcka and Hillman, 1974). The cells of the preimplantation
epiblast are apolar and remain sandwiched between the basal sides
of trophoblast and hypoblast (Enders et al., 1986; Nadijcka and
Hillman, 1974). Consequently, both rodent and primate late
blastocysts set aside the founding population of the ‘embryo
proper’ and specify two extraembryonic lineages for successful
attachment to the uterine wall.
Primate development radically diverges from the rodent
paradigm during implantation. In mouse, the embryo attaches to
the deciduum and epiblast cells arrange themselves radially into a
rosette-like structure between trophoblast and hypoblast (Fig. 1A,
Carnegie stage 4). Epiblast cells establish junctions at the newly
formed apex and concentrate their organelles towards the centre.
This transformation requires basal membrane-stimulated integrin
signalling and results in the formation of a central cavity (Bedzhov
and Zernicka-Goetz, 2014). Trophoblast cells at the proximal end of
the implanting embryo expand to form extraembryonic ectoderm
and the ectoplacental cone (Fig. 1A, Carnegie stages 4 and 5). The
extraembryonic ectoderm also undergoes polarisation and forms a
cup-shaped layer of epithelial cells proximal to the epiblast. At the
same time, the hypoblast diversifies and expands to form parietal
and visceral endoderm. Parietal endoderm migrates along the inner
side of the trophoblast. Visceral endoderm overlies both epiblast and
extraembryonic ectoderm, predominantly forming the endoderm of
the visceral yolk sac (Arnold and Robertson, 2009; Tam and Loebel,
2007), but also contributing to definitive endoderm (Kwon et al.,
2008). Although this part of the developmental programme is
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Fig. 1. Schematic overview of rodent and primate development from fertilisation to gastrulation. Developmental time of rodent development (A) and
primate development (B) is given in Carnegie stages to facilitate comparison between species. Embryonic lineages are represented in blue shades,
extraembryonic lineages in red shades. Cartoons for primate development were drawn based on histological sections of common marmoset (Moore et al., 1985),
rhesus macaque (Enders and King, 1988; Enders et al., 1986) and early human stages of the Carnegie collection (Hertig and Rock, 1941, 1946, 1949; Rock and
Hertig, 1948). Note that extraembryonic mesoderm specification from visceral endoderm is exclusively based on electron micrographs of early rhesus macaque
implantation stages.
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shared between rodent and primate, there is a clear and crucial
exception: the primate embryo establishes two additional
extraembryonic lineages at this stage – the amniotic epithelial
cells and the extraembryonic mesoderm (Fig. 1B, highlighted in
red).
Primates segregate amniotic epithelial cells directly from the peri-
implantation epiblast. During implantation, the primate epiblast
forms a rosette-like structure, similar to mouse, with epiblast cells
underlying the trophoblast sharing desmosomal junctions with
trophoblast cells (Enders et al., 1986). In addition, primate epiblast
cells adjacent to the visceral endoderm increase in size and displace
the centre of the rosette (Fig. 1B, Carnegie stage 4). Lumen
formation in the centre of the implanting rosette gives rise to the
amniotic cavity. These rearrangements yield two morphologically
distinctive cell types: amniotic epithelial cells, which are the
precursors of the amniotic sac, on the cytotrophoblast side; and
postimplantation epiblast cells, destined to form the embryonic disc,
which reside adjacent to visceral endoderm (Fig. 1B, Carnegie
stages 5 to 6). The amnion is a smooth epithelium consisting of low
cuboidal cells linked by apical junctional complexes. It is
contiguous with the taller, columnar epiblast, reflecting their
common origin. Recent progress in the culture of human embryos
to early postimplantation stages in vitro has allowed the direct
observation of amniotic cavity formation (Deglincerti et al., 2016;
Shahbazi et al., 2016). Human epiblast cells acquire apical-basal
polarity, undergo lumen formation and establish columnar and
squamous POU5F1-positive populations, representative of
embryonic disc and prospective amniotic epithelium, respectively
(Deglincerti et al., 2016; Shahbazi et al., 2016). This direct mode of
amnion formation from the preimplantation epiblast before
gastrulation is described in marmoset, rhesus macaque and human
(Fig. 2), suggesting a conserved feature of primate development. A
recent report showing that primate germ cells are specified from
amniotic epithelial cells further underlines the major importance of
this lineage decision (Sasaki et al., 2016). In mouse, amnion
formation is initiated later, at the onset of gastrulation, when
extraembryonic mesoderm is specified from the posterior epiblast
(Fig. 1A, Carnegie stage 6). This leads to formation of the
amniochorionic fold [formerly called the ʻposterior amniotic fold’
(Kaufman, 1992)], which gives rise to both amnion and chorion
(described by Pereira et al., 2011).
The second fundamental difference between rodent and primate
development is extraembryonic mesoderm specification (Fig. 1B,
Carnegie stage 4). In rodents, gastrulation initiates in the primitive
streak, which is induced at the proximal posterior extremity of the
postimplantation epiblast at Carnegie stage 6 (Fig. 1A). Distinct
mesodermal cell lineages become allocated according to the time
and site of ingression through the streak (Arnold and Robertson,
2009; Lawson, 1999). The earliest population of mouse epiblast
cells to undergo epithelial-to-mesenchymal transition and migrate
through the streak gives rise to extraembryonic mesoderm,
including the mesodermal layer of the chorion, visceral yolk sac
mesoderm and blood islands (Arnold and Robertson, 2009). Thus,
in rodents, extraembryonic mesoderm formation occurs during
gastrulation. By contrast, primates specify extraembryonic
mesoderm at implantation, long before gastrulation (Fig. 1B,
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Fig. 2. Images of early primate implantation stages. Carnegie stages 5 and 6 are shown from (A,D) common marmoset (Enders and Lopata, 1999),
(B,E) rhesus macaque (Enders et al., 1986) and (C,F) human stages of the Carnegie collection (Hertig and Rock, 1941; O’Rahilly and Muller, 1987). Blue
arrowheads indicate postimplantation epiblast (A-C) or embryonic disc (D-F), red arrowheads indicate amniotic epithelial cells. Images reproduced with
permission from John Wiley and Sons (A,B,D,E) and the Carnegie Institution of Washington (C,F).
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Carnegie stage 4). Primate visceral endoderm derivatives invade the
space between visceral endoderm and cytotrophoblast (Fig. 1B,
Carnegie stage 4, asterisk). These subendodermal cells appear in
ultrastructure similar to endoderm, but have lost apical junctional
complexes and microvilli, and differentiate into extraembryonic
mesoderm (Enders and King, 1988). As development progresses,
extraembryonic tissues undergo rapid proliferation and displace the
embryo away from the cytotrophoblast. Extraembryonic mesoderm
cells are stellate in appearance and produce copious extracellular
matrix (Enders and King, 1988). The embryonic disc is connected to
the developing placenta via a stalk of amnion termed the amniotic
diverticulum (Enders et al., 1986). Epiblast cells preferentially
divide at the apical surface (Enders et al., 1986), reminiscent of
interkinetic nuclear migration in neuroectoderm. The primitive
streak is initiated posteriorly at the margin of the embryonic disc at
Carnegie stage 6, when epiblast cells start to invade the space
towards visceral endoderm. These embryonic mesodermal cells are
of primitive and undifferentiated appearance, in contrast to their
extraembryonic counterparts, which are characterised by high
motility and extracellular matrix production (Enders and King,
1988).
In summary, primates specify two additional extraembryonic
lineages before gastrulation, with amniotic epithelial cells directly
derived from the peri-implantation epiblast.
Naïve ESCs are functionally equivalent to the
preimplantation epiblast
Naïve pluripotency is defined by the unrestricted developmental
potential to give rise to all somatic lineages and the germline. In
mouse, preimplantation epiblast cells isolated from the late ICM
readily contribute to chimaeras when injected into a host blastocyst
(Gardner and Rossant, 1979). Mouse ESCs can be captured from
individual epiblast cells in naïve culture conditions and resemble the
preimplantation epiblast both transcriptionally and functionally
(Boroviak et al., 2014; Brook and Gardner, 1997). They efficiently
contribute to chimaeras (Alexandrova et al., 2015; Ying et al.,
2008), and ESCs that have downregulated the naïve marker Zfp42
(Rex1) are predominantly eliminated from host embryos
(Alexandrova et al., 2015). Thus, preimplantation epiblast identity
is an integral feature of chimaera-competent ESCs.
We propose that this imperative equally applies in primates.
Therefore, the naïve state exists a priori in the preimplantation
epiblast of the primate blastocyst. It represents a unique state of reset
epigenome combined with a transcription factor configuration
capable of delivering unbiased developmental plasticity. The naïve
transcriptional circuitry has established control over genes required
for cellular growth, organelle proliferation and lipid synthesis,
abrogating the need for cleavage. It generates the first autopoietic
cells of the embryo, equipped to establish secure and unconstrained
nutrition by attachment to the uterus and to initiate the next steps of
embryogenesis. Moreover, the proposition of a naïve state residing
within the primate embryo does not entail that primate naïve
pluripotency simply replicates the rodent paradigm. Primate naïve
ESCs are expected to share more characteristics with rodent ESCs
than with rodent EpiSCs, but in addition differences between naïve
ESCs in rodents and primates are anticipated and even obligate. The
next section of this article focuses on these conserved and
distinctive features as we condense our current knowledge of the
primate preimplantation epiblast into 12 hallmarks of naïve
pluripotency (Fig. 3A). The first seven hallmarks equally apply to
rodents and primates (white in Fig. 3A); the remaining five are
specific to human and non-human primates (turquoise in Fig. 3A).
Hallmarks of naïve pluripotency in primates
1. Unbiased differentiation potential
A defining feature of naïve pluripotency is the uncompromised
ability to differentiate into somatic tissues and the germline in vitro
and in vivo (Fig. 3A). Mouse EpiSCs and primed human ESCs
display heterogeneity in their developmental potential, resulting in
lineage bias (Bernemann et al., 2011; Bock et al., 2011; Han et al.,
2010; Osafune et al., 2008). This variability in differentiation
competence has been attributed to different levels of endogenous
Wnt/β-catenin signalling (Blauwkamp et al., 2012; Davidson et al.,
2012; Kurek et al., 2015). EpiSCs resemble the ectoderm of late
gastrula stage embryos (Kojima et al., 2014), where Wnt/β-catenin
signalling is pivotal for setting up anterior-posterior axis formation
(Huelsken et al., 2000; Liu et al., 1999). Consistent with the rodent
model, primate cells in the postimplantation embryo display
increasing transcriptional heterogeneity towards gastrulation
(Nakamura et al., 2016). In the naïve pluripotent epiblast, the
transcriptional circuitry shields the cells from premature
differentiation prior to implantation and preserves their full
developmental potential.
2. Apolarity
In the outer blastomeres of the morula, establishment of polarity is
associated with differentiation into the trophoblast lineage. Absence
of polarity directs cells towards the inside of the embryo (Anani
et al., 2014), an essential requirement for the establishment of
pluripotency in vivo (Boroviak and Nichols, 2014). At the blastocyst
stage, hypoblast precursor cells differentiate into an epithelium,
while the pluripotent compartment remains sandwiched between
the basal surfaces of trophoblast and hypoblast. In both rodents and
primates, the preimplantation epiblast is an apolar cluster of cells
(Bedzhov and Zernicka-Goetz, 2014; Enders et al., 1986; Plusa
et al., 2005). This changes rapidly upon implantation, when epiblast
cells arrange themselves into a rosette-like structure, concentrate
their organelles at the apical end of the cell and form extensive
adherence junctions (Bedzhov and Zernicka-Goetz, 2014; Enders
et al., 1986). Acquisition of polarity paves the way for amniotic
cavity formation, an essential process in all amniotes. In vitro, the
apolar morphology of the preimplantation epiblast is preserved in
the characteristic dome shape of naïve ESC colonies (Ying et al.,
2008). By contrast, mouse EpiSCs and conventional human ESCs
form flat colonies with ultrastructural characteristics similar to the
postimplantation epiblast epithelium, including the presence of tight
junctions and apical microvilli (Brons et al., 2007; Krtolica et al.,
2007; Sathananthan et al., 2002; Tesar et al., 2007). The survival
and proliferation of cells in epithelial structures is tightly controlled,
rendering primed cells vulnerable to apoptosis upon single-cell
dissociation (Ohgushi et al., 2010; Watanabe et al., 2007). This
presents a major obstacle for successful chimaera formation upon
blastocyst injection, but may be reversed in human reset ESCs
maintained with aPKC inhibition (Takashima et al., 2014). aPKC is
a kinase known to be essential for the establishment of apical-basal
polarity from worms to man (Izumi et al., 1998; Suzuki et al., 2001).
It is tempting to speculate that blocking the acquisition of epithelial
polarity might interfere with differentiation towards a
postimplantation epiblast state. Nevertheless, genetic studies will
be required to ascertain the role of apical polarity proteins in the
transition towards primed pluripotency.
3. ERK independence
Primed cultures require active FGF signalling. During blastocyst
development, there is accumulating evidence that FGF/ERK
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inhibition promotes epiblast formation across species. In mouse, the
FGF/ERK cascade is the predominant driver of hypoblast
specification (Nichols et al., 2009; Yamanaka et al., 2010),
whereas primates rely on additional signalling pathways
(Boroviak et al., 2015; Kuijk et al., 2012; Roode et al., 2012).
However, robust expression of NANOG in the absence of FGF/
ERK signalling is reported in mouse, rat, bovine, marmoset and
human blastocysts (Boroviak et al., 2015; Kuijk et al., 2012; Nichols
et al., 2009; Roode et al., 2012). A recent study demonstrates similar
findings in the zebra finch blastoderm (Mak et al., 2015), suggesting
high conservation of the inverse correlation between naïve
pluripotency and FGF/ERK signalling among amniotes.
4. Autopoiesis
The totipotent zygote undergoes cleavage divisions in the absence
of cellular growth or increase in embryo mass. Cleavage occurs
until the mid-blastocyst stage, when epiblast and hypoblast are
specified (Aiken et al., 2004). The birth of naïve pluripotency in
the epiblast is tightly linked to the establishment of autopoiesis
(from the Greek meaning ʻself-creating’). In biology, autopoiesis
refers to the ability of a cell to fully reproduce and maintain itself,
that is, to ʻself-produce’ all the same organelles, membranes and
cytosolic components of which it is composed. This differs from
the concept of self-renewal, which relates to the renewal of
developmental potential and not necessarily the full self-renewal
of cellular components per se. In mouse, embryonic cells gain
autopoiesis just before implantation, when a safe and continuous
nutrient supply is within reach (Aiken et al., 2004; Boroviak and
Nichols, 2014). Cleavage stage and early ICM cells are unable to
replenish their cytosolic compartment before cell division,
precluding them from continuous and stable self-renewal
(Boroviak et al., 2014; Boroviak and Nichols, 2014). In the
primate embryo, precise measurements of nucleocytoplasmic
ratios throughout preimplantation development are not yet
available. However, measurements of cell sizes from histological
sections (The Virtual Human Embryo, www.ehd.org/virtual-
human-embryo/) suggest a decrease from morula and early ICM
to the late blastocyst stage and constant or larger sizes at early
postimplantation stages. Thus, it seems plausible that human and
non-human primate embryos equally acquire autopoiesis around
implantation. We suggest that autopoiesis is a hallmark of naïve
pluripotency, distinguishing it from totipotent cleavage stages.
5. Core pluripotency
Pluripotency is conferred by a unique array of transcription
factors. At the core of this network are POU5F1, SOX2 and
NANOG, which are evolutionarily conserved in mammals and
several vertebrates (Dixon et al., 2010; Lavial et al., 2007; Tapia
et al., 2012; Theunissen et al., 2011) and robustly expressed in
both rodent and primate preimplantation epiblasts (Blakeley et al.,
2015; Boroviak et al., 2015; Petropoulos et al., 2016).
Interestingly, the core circuitry is shared between naïve and
primed pluripotent cells, suggesting a context-dependent role in
transcriptional regulation (Boiani and Scholer, 2005; Buecker
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et al., 2014). In mouse epiblast and ESCs, the framework is
provided by naïve pluripotency factors such as Klf2, Klf4, Klf5,
Esrrb, Tfcp2l1, Tbx3 and Zfp42. This naïve circuitry is specifically
expressed in pre- but not postimplantation development (Boroviak
et al., 2014). Upon implantation in rodents, the wider pluripotency
network is replaced with a different suite of transcription factors,
including Otx2, Pou3f1 (Oct6), Sox3, Tead2 and Bex1 (Acampora
et al., 2013; Boroviak et al., 2015) to prepare the epiblast for
gastrulation. Nanog is downregulated at early postimplantation
stages in mouse. It has been proposed that during this formative
phase, in the absence of both naïve factors and lineage specifiers,
cells become receptive to differentiation stimuli (Kalkan and
Smith, 2014; Smith, 2017). Subsequently, Nanog becomes re-
expressed in the mouse posterior epiblast; localised expression of
Wnt, Nodal and Bmp initiate primitive streak formation and
establishment of the primary germ layers commences. Recent
transcriptome profiling of non-human primate postimplantation
stages revealed uninterrupted expression of POU5F1, SOX2 and
NANOG until gastrulation (Nakamura et al., 2016). This lends
support to the crucial role of the core pluripotency network across
developmental states.
6. DNA hypomethylation
The naïve character of the epiblast extends to epigenetic marks.
DNA methylation carries important regulatory information and
undergoes global resetting during germ cell and preimplantation
development (Seisenberger et al., 2013a,b). In mouse and human,
the preimplantation epiblast has a distinctive epigenetic signature
consisting of genome-wide DNA hypomethylation with only the
imprinted regions spared (Guo et al., 2014; Smallwood et al., 2011;
Smith et al., 2014, 2012). This epigenetic status is preserved in
mouse ESCs cultured in 2i/LIF, but not in serum-based conditions
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013).
Conventional human ESCs exhibit high DNA methylation levels
comparable to those of mouse EpiSCs, ESCs cultured in serum/LIF,
or human somatic cells (Pastor et al., 2016). Resetting human ESCs
with either 5i/L/FA (Theunissen et al., 2014) or t2iL+Gö
(Takashima et al., 2014) induces hypomethylation at levels
similar to the human ICM, but at the expense of DNA
methylation of primary imprints (Pastor et al., 2016; Theunissen
et al., 2016). This is problematic, since erroneous imprinting is
implicated in a variety of human diseases and syndromes (Butler,
2009). Also, prolonged culture of human ESCs in 5i/L/FA leads to
karyotypic abnormalities (Pastor et al., 2016; Theunissen et al.,
2014), but whether loss of DNAmethylation is the underlying cause
remains to be elucidated.
7. Active X chromosomes
Most mammals exhibit random X-chromosome inactivation (XCI)
in females to compensate X-linked gene expression (Escamilla-Del-
Arenal et al., 2011; van den Berg et al., 2011). In mouse, the
paternal X chromosome is silenced at the 4-cell stage (Huynh and
Lee, 2003) and remains inactive in extraembryonic tissues.
However, the paternal X chromosome is reactivated in the epiblast
(Mak et al., 2004; Okamoto et al., 2004), tightly linked to the
establishment of naïve pluripotency (Silva et al., 2009). In human
blastocysts, transcription occurs from both X chromosomes in the
preimplantation epiblast, as in mouse (Petropoulos et al., 2016).
XCI ensues upon implantation and is associated with the
establishment of primed pluripotency (Kobayashi et al., 2016).
Thus, the presence of dually active X chromosomes is a hallmark of
naïve pluripotency.
8. XIST expression
In mouse, XCI is mediated by the cis-acting, non-coding RNA Xist,
which is downregulated in the epiblast. Re-expression occurs in the
early postimplantation epiblast from either the maternal or paternal
X chromosome to induce random XCI. By contrast, rabbit embryos
initially upregulate Xist on both X chromosomes and, via an
intermediate phase of biallelic XCI, induce random, monoallelic
XCI at the late blastocyst stage before gastrulation (Okamoto et al.,
2011). Consequently, biallelic X chromosome expression is not a
hallmark of naïve pluripotency in the rabbit embryo.
Human embryos also lack paternal imprints for XIST expression,
similar to rabbits, resulting in random XCI in both embryonic and
extraembryonic lineages. However, despite biallelic XIST
expression in more than half of the cells examined, both X
chromosomes remain transcriptionally active in human blastocysts
(Okamoto et al., 2011). Random XCI presumably occurs upon
implantation, similar to in mice. Recent single-cell transcriptome
data of human ICM cells confirm XIST expression at the blastocyst
stage (Blakeley et al., 2015; Petropoulos et al., 2016; Yan et al.,
2013). However, in contrast to mouse, dosage compensation occurs
gradually in all three lineages of the human blastocyst, with both X
chromosomes being actively transcribed throughout this process
(Petropoulos et al., 2016). The mechanisms of dosage compensation
in the presence of biallelic XIST expression remain unknown.
Nevertheless, the embryo transcriptome data show that female
human naïve pluripotent cells are expected to express XIST with
both X chromosomes being active. This has been demonstrated
recently for 5i/L/FA and t2iL+Gö reset cells (Sahakyan et al., 2016)
and is in contrast to female naïve pluripotent cells in rodents, which
do not express XIST.
9. Primate-specific naïve network
Naïve pluripotency factors are exclusive to preimplantation stages
and sharply downregulated upon implantation and epiblast
epithelialisation. Therefore, their identification relies on
transcriptional analysis of both pre- and postimplantation samples.
Naïve pluripotency factors in mouse include Klf2, Klf4, Klf5, Stat3,
Nr0b1, Esrrb, Tfcp2l1, Tbx3 and Zfp42 (Boroviak et al., 2014,
2015; Peng et al., 2016; Scialdone et al., 2016). A subset of naïve
factors, including Stat3 (Yang et al., 2010), Nr5a2 (Guo and Smith,
2010), Klf2 (Hall et al., 2009), Esrrb (Festuccia et al., 2012), Klf4
(Guo et al., 2009) and Tfcp2l1 (Martello et al., 2013) can single-
handedly drive naïve conversion from EpiSCs, and combinations of
NANOG plus KLF2 or KLF4 have been used to reset human ESCs
(Takashima et al., 2014; Theunissen et al., 2014).
The advent of single-cell profiling has allowed detailed molecular
mapping of primate preimplantation development, and RNA
sequencing (RNA-seq) datasets have become available in
marmoset (Boroviak et al., 2015) and human (Blakeley et al.,
2015; Petropoulos et al., 2016; Xue et al., 2013; Yan et al., 2013)
showing that the majority of pluripotency-associated genes,
including POU5F1, SOX2, NANOG, SALL4, KLF4, TFCP2L1
and TDGF1 are expressed in the primate epiblast. TFCP2L1, KLF4
and NANOG proteins colocalise in a subset of ICM cells in
marmoset (Boroviak et al., 2015) and human (Takashima et al.,
2014) blastocysts, suggesting partial conservation of the naïve
circuitry. However, absence of KLF2, ESRRB, NR0B1, FBXO15
and BMP4, and increased levels of GDF3, NODAL, LEFTY1,
KLF17 and ARGFX, demonstrate extensive primate-specific
adaptation of the naïve pluripotency network (Blakeley et al.,
2015; Boroviak et al., 2015; Petropoulos et al., 2016).
Postimplantation stages in human are impossible to obtain for
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ethical reasons, but a recent report in cynomologus monkey
provided a transcriptional blueprint from ICM to the late gastrula
(Nakamura et al., 2016). Naïve markers expressed in the
preimplantation epiblast but not in postimplantation stages
included TFCP2L1, KLF5, KLF17, NODAL and SOX15
(Nakamura et al., 2016). KLF4 and DNMT3L were drastically
downregulated upon implantation, but still expressed in the early
postimplantation epiblast. The generation of chimaera-competent
primate ESCswill rely on the complete re-establishment of the naïve
circuitry that is operative in the preimplantation epiblast, free from
expression of the mouse-specific KLF2, ESRRB and NR0B1.
10. Primate-specific transposable element (TE) expression
Global resetting of the epigenome during early development
impacts on the expression of TEs, which make up half of the
mammalian genome. Liberation from repressive DNA methylation
in early developmental stages results in highly stage-specific TE
expression (Göke et al., 2015). This transposcriptome has been
proposed as an alternative measure to assess the correspondence
between cultured pluripotent stem cells and the embryo (Theunissen
et al., 2016). Human 5i/L/FA (Theunissen et al., 2014) and t2iL+Gö
(Takashima et al., 2014) reset cells resemble human morula and
blastocyst stages, respectively, showing elevated expression of the
SINE-VNTR-Alu D subgroup (SVA-D) and LTR5_Hs (Theunissen
et al., 2016). The close correlation to results from gene-based
methods supports the overall conclusion of this new TE signature-
based approach. However, while the transposcriptome may provide
a more sensitive measure of the cell state in terms of transcript
number, the functional relevance of similarities and divergences
remains to be explored.
11. Slower proliferation
An important divergence between rodents and primates is the rate of
proliferation. The mouse late blastocyst consists of ∼150 cells at
embryonic day (E) 4.5 (Plusa et al., 2008), reflecting a cell cycle
length of ∼15 h. Human embryos reach this stage after 7 days,
having generated ∼250 cells (Niakan and Eggan, 2013). Thus,
human embryonic cells have an increase in cell cycle length of at
least 6 h, from 15 h to 21 h. Mouse ESCs exhibit comparable
generation times (14-16 h) to their embryonic counterpart (Jovic
et al., 2013), largely as a result of elevated and cell cycle-
independent cyclin-dependent kinase 2 (Cdk2) expression (Stead
et al., 2002). Cdk2 promotes the G1–S-phase transition by initiating
DNA replication. By contrast, human (Blakeley et al., 2015; Yan
et al., 2013) and marmoset (Boroviak et al., 2015) ICM cells lack
constitutive CDK2 expression, but show higher levels of WEE1, a
key cell cycle inhibitor. This demonstrates major differences in the
cell cycle machinery between rodents and primates. Thus, authentic
primate ESCs are not expected to typify their rodent counterparts
with regard to proliferation rates.
12. Extraembryonic potential
The divergence of rodent and primate postimplantation
development transforms the concept and prospects of naïve
pluripotency in primates. In contrast to mouse epiblasts, primates
segregate an additional lineage before gastrulation, whereby the
proximal epiblast differentiates into amniotic epithelium (Enders
and Lopata, 1999; Enders et al., 1986). We therefore hypothesise
that authentic human naïve pluripotent cultures should have an
expanded capacity to produce both postimplantation epiblast and
amniotic epithelial cells. This means that naïve primate ESCs
should be able to differentiate into either cell type within a short
time window. However, currently there are two key pieces of
information missing: (1) the signalling pathways that control this
lineage decision; and (2) the transcriptional and epigenetic signature
of amniotic epithelial cells. A clear understanding of the
developmental cues that determine amnion differentiation will be
required to specify this extraembryonic lineage efficiently from
naïve primate ESCs in vitro. Moreover, this experiment demands a
detailed knowledge of the molecular signature of amniotic epithelial
cells in vivo for meaningful endpoint analysis. Future studies of non-
human primate postimplantation development including samples of
amniotic epithelial cells and tracking of spatial identity within the
embryo might be able to tackle these questions.
The 12 hallmarks: a testable framework for human naïve
ESCs
We propose that the 12 hallmarks of naïve pluripotency outlined
above can constitute a powerful system to assess human naïve
pluripotency in vitro. Primate cells in a naïve state are expected to
tolerate long-termMEK inhibition via PD0325901 (hallmark 3) and
to grow more slowly than mouse ESCs (hallmark 11) in apolar,
dome-shaped colonies (hallmark 2). Absence of epithelial character
can be further examined by antibody staining for apical polarity and
tight junction proteins. The autopoietic nature of the cells allows
stable long-term propagation (hallmark 4), distinguishing them
from totipotent cells, which cannot be propagated indefinitely.
Hypomethylation can be evaluated by bisulphite sequencing
(hallmark 6). Genome-wide transcriptional profiling by RNA-seq
permits testing for core pluripotency (hallmark 5), XIST expression
(hallmark 8), the primate-specific naïve network (hallmark 9) and
TE expression (hallmark 10). Read lengths of more than 100 bp are
favourable to facilitate mapping of highly repetitive TEs. Moreover,
exploring the wider naïve transcriptional circuitry and the TE
signature are powerful ways to discriminate between primate
epiblast identity and artificial mouse ESC-like states. Absence or
low-level expression of mouse-specific pluripotency factors,
including KLF2, ESRRB, NR0B1 and FBXO15, are important
indicators for successful resetting towards an authentic human
epiblast state. High-quality RNA-seq datasets may also be used to
detect SNPs and assess biallelic expression from the X chromosome
(hallmark 7). Alternatively, the X-chromosome activation status can
be determined by fluorescence in situ hybridisation (hallmark 7).
In addition to descriptive analysis, it is pivotal to test functionally
unbiased differentiation potential (hallmark 1) and extraembryonic
capacity for amnion formation (hallmark 12). Human germline
chimaera contribution assays are prohibited on ethical grounds.
However, unbiased differentiation can be gauged in vitro and by
teratoma formation in vivo. Froma developmental point of view, naïve
ESCs are expected to differentiate into somatic lineages via successive
formative and primed pluripotent states (Smith, 2017). This needs to
be considered when applying stepwise protocols for directed
differentiation. Epigenetic resetting to the naïve state may eradicate
someof the lineagebias observed in conventional humanESCs.These
experiments demand careful quantification of various differentiation
assays and would only become meaningful after comparing multiple
independent lines. Moreover, it is difficult to discern genetic diversity
from epigenetic lineage bias. In practice, quantitative differentiation
might not be suitable for routine assessment of naïve pluripotency.
The specific ability of the primate peri-implantation epiblast to
give rise to nascent amnion (hallmark 12) might provide a more
explicit functional assay to discriminate between naïve and primed
states. Conventional human ESCs correspond to the pregastrula
embryonic disc (Nakamura et al., 2016), 7 days after amnion
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segregation. Naïve pluripotency is established in the epiblast just
before this decision point. Thus, naïve human ESCs should be
competent to replicate amnion segregation and amniotic cavity
formation of postimplantation stages. Stimuli from the extracellular
matrix and/or adjacent extraembryonic tissues might be essential for
this transition. The recent reports on amniotic cavity formation of
human embryos cultured to postimplantation stages in vitro
(Deglincerti et al., 2016; Shahbazi et al., 2016) lend support to
the feasibility of this undertaking. An in vitro system to obtain and
study human embryonic and extraembryonic lineages from cultured
cells would be highly desirable to unravel the continuum of
pluripotent states in the primate embryo.
Unresolved issues in primate development
Several features of naïve pluripotency remain uncertain in primates
(Fig. 3B). Mouse ESCs are bivalent in their energy production, using
both oxidative phosphorylation and glycolysis, whereas EpiSCs shift
their metabolism to high glycolysis, phenotypically akin to rapidly
proliferating cancer cells (Zhou et al., 2012). A number of recent
studies have characterised metabolic dynamics in different pluripotent
states in vitro (reviewed byTeslaa andTeitell, 2015); however,whether
this paradigm applies to bona fide primate embryonic development
remains unclear. While quantitative measurements of metabolites or
oxygen consumption rates are difficult to obtain in vivo, results from in
vitro derived cells might not reflect the situation in the embryo. For
example, it has been suggested that nicotinamide N-methyltransferase
(NNMT) regulates a metabolic switch between human primed and
putative naïve ESCs cultured in 2i/FGF (Sperber et al., 2015).
However, NNMT is not expressed in the human preimplantation
epiblast (Blakeley et al., 2015; Petropoulos et al., 2016; Yan et al.,
2013). Another contentious subject is NODAL/TGFβ signalling in the
primate blastocyst. Human embryos cultured in the presence of
the NODAL/TGFβ inhibitor SB431542 are reported to increase the
number of NANOG-positive ICM cells (Van der Jeught et al., 2014).
However, similar experiments using higher concentrations showed a
dramatic reduction of NANOG expression (Blakeley et al., 2015). In
marmoset, NODAL/TGFβ inhibition with A83-01 did not modulate
NANOG expression (Boroviak et al., 2015). The question of whether
NODAL/TGFβ signalling is functionally required for primate naïve
pluripotency is interesting and deserves further attention. Equally
unclear is the role of LIF/STAT3 signalling or whether POU5F1
expression in the embryo primarily relies on its distal enhancer. So far,
specificPOU5F1 distal enhancer operation has not been demonstrated
in the primate epiblast. Further refinements of ChIP-seq and advanced
chromosome configuration capture approaches for single-cell analysis
will help to address some of these questions.
Future perspectives of naïve pluripotency in primates
The capture of authentic developmental states forms an integral part
of both basic and applied research. Naïve ESCs provide a tool to
functionally assess the factors that control in vivo development. This
is of particular importance in primates, where embryonic material is
precious and scarce. Second, robust differentiation of pluripotent
cells relies on a precise spatiotemporal sequence of specification
events. A defined developmental starting point is essential to mimic
embryonic patterning in vitro. Preimplantation epiblast identity
delivers an exact developmental stage with well-defined
characteristics (Fig. 3A), in addition to favourable cell biology
features such as apolarity for efficient single-cell cloning. Despite
the remarkable success of designer nucleases (Liu et al., 2014; Sato
et al., 2016) and Cas9/RNA-mediated gene targeting (Niu et al.,
2014) in non-human primate zygotes, it is technically and
economically challenging to obtain sufficient numbers of primate
embryos for knock-in strategies. Currently, this limits gene-editing
approaches to simple gene disruption.
Chimaera-competent ESCs in non-human primates might open up
avenues for sophisticated genetic engineering to create versatile
models for basic and preclinical research. This is important in areas
where rodent models are insufficient, including infectious diseases,
neurodegenerative disorders, aging and reproductive medicine
(Carrion and Patterson, 2012; Mansfield, 2003; Okano et al., 2012;
Shedlock et al., 2009). Another emerging application for naïve ESCs
in biomedical research is organ farming. Rat ESCs are capable of
filling the developmental niche of mouse Pdx1 (pancreatogenesis-
disabled) null host embryos (Kobayashi et al., 2010), a procedure
referred to as interspecies chimaeric complementation (reviewed by
Wu and Izpisua Belmonte, 2015). This concept might be exploited to
grow human organs in pigs for xenotransplantation. The recent
generation of apancreatic pigs provides another key step towards
clinical application (Matsunari et al., 2013). However, the lack of
chimaera-competent primate ESCs currently presents a bottleneck for
the generation of primate organs in farm animals. In addition, there are
ethical concernswith regard to unwanted tissue contribution of human
cells to the pig central nervous system or gametes. The use of naïve
non-human primate ESCs in interspecies chimaeric complementation
will be pivotal to resolve these issues and turn the xenomedical vision
into reality.
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and Schöler, H. R. (2011). Distinct developmental ground states of epiblast stem
cell lines determine different pluripotency features. Stem Cells 29, 1496-1503.
Blakeley, P., Fogarty, N. M. E., del Valle, I., Wamaitha, S. E., Hu, T. X., Elder, K.,
Snell, P., Christie, L., Robson, P. and Niakan, K. K. (2015). Defining the three
cell lineages of the human blastocyst by single-cell RNA-seq. Development 142,
3151-3165.
183
HYPOTHESIS Development (2017) 144, 175-186 doi:10.1242/dev.145177
D
E
V
E
LO
P
M
E
N
T
Blauwkamp, T. A., Nigam, S., Ardehali, R., Weissman, I. L. andNusse, R. (2012).
Endogenous Wnt signalling in human embryonic stem cells generates an
equilibrium of distinct lineage-specified progenitors. Nat. Commun. 3, 1070.
Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., Ziller,
M., Croft, G. F., Amoroso, M. W., Oakley, D. H. et al. (2011). Reference maps of
human ES and iPS cell variation enable high-throughput characterization of
pluripotent cell lines. Cell 144, 439-452.
Boiani, M. and Scholer, H. R. (2005). Regulatory networks in embryo-derived
pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 6, 872-884.
Boroviak, T. and Nichols, J. (2014). The birth of embryonic pluripotency. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 369.
Boroviak, T., Loos, R., Bertone, P., Smith, A. and Nichols, J. (2014). The ability of
inner-cell-mass cells to self-renew as embryonic stem cells is acquired following
epiblast specification. Nat. Cell Biol. 16, 516-528.
Boroviak, T., Loos, R., Lombard, P., Okahara, J., Behr, R., Sasaki, E., Nichols,
J., Smith, A. and Bertone, P. (2015). Lineage-specific profiling delineates the
emergence and progression of naive pluripotency in mammalian embryogenesis.
Dev. Cell 35, 366-382.
Bradley, A., Evans, M., Kaufman, M. H. and Robertson, E. (1984). Formation of
germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309,
255-256.
Braude, P., Bolton, V. and Moore, S. (1988). Human gene expression first occurs
between the four- and eight-cell stages of preimplantation development. Nature
332, 459-461.
Brons, I. G. M., Smithers, L. E., Trotter, M. W. B., Rugg-Gunn, P., Sun, B., Chuva
de Sousa Lopes, S. M., Howlett, S. K., Clarkson, A., Ahrlund-Richter, L.,
Pedersen, R. A. et al. (2007). Derivation of pluripotent epiblast stem cells from
mammalian embryos. Nature 448, 191-195.
Brook, F. A. and Gardner, R. L. (1997). The origin and efficient derivation of
embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 94, 5709-5712.
Buecker, C., Chen, H.-H., Polo, J. M., Daheron, L., Bu, L., Barakat, T. S.,
Okwieka, P., Porter, A., Gribnau, J., Hochedlinger, K. et al. (2010). A murine
ESC-like state facilitates transgenesis and homologous recombination in human
pluripotent stem cells. Cell Stem Cell 6, 535-546.
Buecker, C., Srinivasan, R., Wu, Z., Calo, E., Acampora, D., Faial, T., Simeone,
A., Tan, M., Swigut, T. and Wysocka, J. (2014). Reorganization of enhancer
patterns in transition from naive to primed pluripotency. Cell Stem Cell 14,
838-853.
Butler, M. G. (2009). Genomic imprinting disorders in humans: a mini-review.
J. Assist. Reprod. Genet. 26, 477-486.
Carrion, R., Jr and Patterson, J. L. (2012). An animal model that reflects human
disease: the common marmoset (Callithrix jacchus).Curr. Opin. Virol. 2, 357-362.
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